Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.870
0.00 (0.00%)
At close: Nov 25, 2025, 4:00 PM EST
1.879
+0.009 (0.49%)
After-hours: Nov 25, 2025, 5:40 PM EST

Caribou Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
9.39.9934.4813.859.612.36
Upgrade
Revenue Growth (YoY)
-19.00%-71.01%148.91%44.31%-22.35%113.56%
Upgrade
Cost of Revenue
128.56129.55112.0882.2352.2634.43
Upgrade
Gross Profit
-119.26-119.56-77.6-68.38-42.66-22.06
Upgrade
Selling, General & Admin
35.5642.5638.4638.0224.3214.06
Upgrade
Operating Expenses
20.5842.5638.4638.0224.3214.06
Upgrade
Operating Income
-139.84-162.12-116.06-106.4-66.98-36.12
Upgrade
Interest Expense
------0.02
Upgrade
Interest & Investment Income
9.7415.315.3--0.24
Upgrade
Other Non Operating Income (Expenses)
1.052.2-1.127.18-1.210.51
Upgrade
EBT Excluding Unusual Items
-138.21-144.61-101.88-99.22-68.19-35.39
Upgrade
Merger & Restructuring Charges
-2.88-0.6----
Upgrade
Gain (Loss) on Sale of Investments
----0.13--0.73
Upgrade
Legal Settlements
-3.9-3.9----
Upgrade
Other Unusual Items
----1.58-
Upgrade
Pretax Income
-157.14-149.11-101.88-99.35-66.6-36.13
Upgrade
Income Tax Expense
-0.01-0.010.190.070.32-1.82
Upgrade
Net Income
-157.13-149.11-102.07-99.42-66.92-34.31
Upgrade
Net Income to Common
-157.13-149.11-102.07-99.42-66.92-34.31
Upgrade
Shares Outstanding (Basic)
93907461329
Upgrade
Shares Outstanding (Diluted)
93907461329
Upgrade
Shares Change (YoY)
3.20%22.37%21.39%92.02%270.47%2.05%
Upgrade
EPS (Basic)
-1.70-1.65-1.38-1.64-2.11-4.01
Upgrade
EPS (Diluted)
-1.70-1.65-1.38-1.64-2.11-4.01
Upgrade
Free Cash Flow
-127.73-143.08-104.9-97.42-34.64-33.53
Upgrade
Free Cash Flow Per Share
-1.38-1.58-1.42-1.60-1.09-3.92
Upgrade
Gross Margin
---225.07%---178.50%
Upgrade
Operating Margin
-1504.47%-1622.13%-336.63%-768.17%-697.84%-292.24%
Upgrade
Profit Margin
-1690.45%-1491.94%-296.05%-717.79%-697.26%-277.55%
Upgrade
Free Cash Flow Margin
-1374.19%-1431.66%-304.27%-703.34%-360.91%-271.27%
Upgrade
EBITDA
-135.69-158.19-112.53-104.78-66-35.22
Upgrade
EBITDA Margin
------284.96%
Upgrade
D&A For EBITDA
4.153.933.531.620.980.9
Upgrade
EBIT
-139.84-162.12-116.06-106.4-66.98-36.12
Upgrade
EBIT Margin
------292.24%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q